Smart Pills Technology Market By Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), By Target Area (Esophagus, Stomach, Small Intestine, Large Intestine), By Disease Indication (Barrett'S Esophagus, Small Bowel Diseases, Colon Cancer, Others), By End User (Hospitals and Clinics, Diagnostic Centres, Research Centres): Global Opportunity Analysis and Industry Forecast, 2020-2030
Smart pills are capsule-sized ingestible medical devices consisting of elements such as sensors, cameras, patches, and trackers that help in better diagnostics, patient monitoring, as well as targeted drug delivery. They are majorly available in the form of vitamin capsule-sized pills and possess a small wearable sensor patch, an application on a mobile device, and a provider portal. Once swallowed, it gets activated in the gut; the sensors provide information about the patient’s health parameters and the effectiveness of medication treatment leading to more informed healthcare decisions and optimized therapies. Moreover, smart pills have revolutionized the field of gastrointestinal diagnosis. These pills are non-invasive, and hence the user can be a potent alternative approach against invasive procedures such as gastrointestinal endoscopy/colonoscopy.
A considerable increase in the geriatric population, rise in chronic disorders such as cancer, diabetes, and others, and surge in prevalence of lifestyle-related disorders, such as obesity, gastroesophageal reflux disease (GERD), gastric ulcers, and others majorly drive the growth of the smart pills market. In addition, increased R&Dinvestments in developing smart pills further boost the market growth. However, stringent government regulations regarding the increased use of these devices and the high cost associated with the ingestible sensors are the factors anticipated to restrain the growth of the market.
The smart pills market is segmented based on application, target area, disease indication, end-users, and region. On the basis of application, the market is divided into capsule endoscopy, drug delivery, and patient monitoring. By target areas, the market is divided into the esophagus, stomach, small intestine, and large intestine. By disease indication, the market is segmented into Barrett's esophagus disease, small bowel disease (bifurcated into Crohn's disease, small bowel tumor, celiac disease, and others), Colon Disease, and Others. By end-user, the smart pills market is divided into hospitals & clinics, diagnostic centers, and research centers.
By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Product development and research collaborations are the key strategies adopted by market players. The report provides a comprehensive analysis of the key players that operate in the global smart pills market.
The key players operating in the global smart pills market include CapsoVision, Inc., Check-Cap Ltd., HQ.Inc., IntroMedic Co., Ltd, JINSHAN Science & Technology, Koninklijke Philips N.V., Medtronic plc, OLYMPUS Corporation, Proteus Digital Health, RF Co., Ltd.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the smart pills technology market analysis from 2020 to 2030 to identify the prevailing smart pills technology market opportunities.
The Market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the smart pills technology market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global smart pills technology market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By BY APPLICATION
Capsule Endoscopy
Drug Delivery
Patient Monitoring
By BY TARGET AREA
Esophagus
Stomach
Small Intestine
Large Intestine
By BY DISEASE INDICATION
Barrett'S Esophagus
Small Bowel Diseases
Colon Cancer
Others
By BY END USER
Hospitals and Clinics
Diagnostic Centres
Research Centres
By BY REGION
North America
U.S
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest Of Asia Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
RF Co., Ltd
JINSHAN Science and Technology
Proteus Digital Health
HQ, Inc.
CapsoVision, Inc.
Medtronic Plc.
Olympus Corporations
IntroMedic Co., Ltd
Check Cap
Koninklijke Philips N.V
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: SMART PILLS TECHNOLOGY MARKET, BY APPLICATION
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Capsule Endoscopy
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Drug Delivery
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Patient Monitoring
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- CHAPTER 5: SMART PILLS TECHNOLOGY MARKET, BY TARGET AREA
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Esophagus
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Stomach
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Small Intestine
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- 5.5 Large Intestine
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
- CHAPTER 6: SMART PILLS TECHNOLOGY MARKET, BY DISEASE INDICATION
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Barrett'S Esophagus
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Small Bowel Diseases
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Colon Cancer
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- 6.5 Others
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market analysis by country
- CHAPTER 7: SMART PILLS TECHNOLOGY MARKET, BY END USER
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 Hospitals and Clinics
- 7.2.1 Key market trends, growth factors and opportunities
- 7.2.2 Market size and forecast, by region
- 7.2.3 Market analysis by country
- 7.3 Diagnostic Centres
- 7.3.1 Key market trends, growth factors and opportunities
- 7.3.2 Market size and forecast, by region
- 7.3.3 Market analysis by country
- 7.4 Research Centres
- 7.4.1 Key market trends, growth factors and opportunities
- 7.4.2 Market size and forecast, by region
- 7.4.3 Market analysis by country
- CHAPTER 8: SMART PILLS TECHNOLOGY MARKET, BY REGION
- 8.1 Overview
- 8.1.1 Market size and forecast
- 8.2 North America
- 8.2.1 Key trends and opportunities
- 8.2.2 North America Market size and forecast, by Application
- 8.2.3 North America Market size and forecast, by Target Area
- 8.2.4 North America Market size and forecast, by Disease Indication
- 8.2.5 North America Market size and forecast, by End User
- 8.2.6 North America Market size and forecast, by country
- 8.2.6.1 U.S.
- 8.2.6.1.1 Market size and forecast, by Application
- 8.2.6.1.2 Market size and forecast, by Target Area
- 8.2.6.1.3 Market size and forecast, by Disease Indication
- 8.2.6.1.4 Market size and forecast, by End User
- 8.2.6.2 Canada
- 8.2.6.2.1 Market size and forecast, by Application
- 8.2.6.2.2 Market size and forecast, by Target Area
- 8.2.6.2.3 Market size and forecast, by Disease Indication
- 8.2.6.2.4 Market size and forecast, by End User
- 8.2.6.3 Mexico
- 8.2.6.3.1 Market size and forecast, by Application
- 8.2.6.3.2 Market size and forecast, by Target Area
- 8.2.6.3.3 Market size and forecast, by Disease Indication
- 8.2.6.3.4 Market size and forecast, by End User
- 8.3 Europe
- 8.3.1 Key trends and opportunities
- 8.3.2 Europe Market size and forecast, by Application
- 8.3.3 Europe Market size and forecast, by Target Area
- 8.3.4 Europe Market size and forecast, by Disease Indication
- 8.3.5 Europe Market size and forecast, by End User
- 8.3.6 Europe Market size and forecast, by country
- 8.3.6.1 Germany
- 8.3.6.1.1 Market size and forecast, by Application
- 8.3.6.1.2 Market size and forecast, by Target Area
- 8.3.6.1.3 Market size and forecast, by Disease Indication
- 8.3.6.1.4 Market size and forecast, by End User
- 8.3.6.2 France
- 8.3.6.2.1 Market size and forecast, by Application
- 8.3.6.2.2 Market size and forecast, by Target Area
- 8.3.6.2.3 Market size and forecast, by Disease Indication
- 8.3.6.2.4 Market size and forecast, by End User
- 8.3.6.3 U.K.
- 8.3.6.3.1 Market size and forecast, by Application
- 8.3.6.3.2 Market size and forecast, by Target Area
- 8.3.6.3.3 Market size and forecast, by Disease Indication
- 8.3.6.3.4 Market size and forecast, by End User
- 8.3.6.4 Italy
- 8.3.6.4.1 Market size and forecast, by Application
- 8.3.6.4.2 Market size and forecast, by Target Area
- 8.3.6.4.3 Market size and forecast, by Disease Indication
- 8.3.6.4.4 Market size and forecast, by End User
- 8.3.6.5 Spain
- 8.3.6.5.1 Market size and forecast, by Application
- 8.3.6.5.2 Market size and forecast, by Target Area
- 8.3.6.5.3 Market size and forecast, by Disease Indication
- 8.3.6.5.4 Market size and forecast, by End User
- 8.3.6.6 Rest of Europe
- 8.3.6.6.1 Market size and forecast, by Application
- 8.3.6.6.2 Market size and forecast, by Target Area
- 8.3.6.6.3 Market size and forecast, by Disease Indication
- 8.3.6.6.4 Market size and forecast, by End User
- 8.4 Asia-Pacific
- 8.4.1 Key trends and opportunities
- 8.4.2 Asia-Pacific Market size and forecast, by Application
- 8.4.3 Asia-Pacific Market size and forecast, by Target Area
- 8.4.4 Asia-Pacific Market size and forecast, by Disease Indication
- 8.4.5 Asia-Pacific Market size and forecast, by End User
- 8.4.6 Asia-Pacific Market size and forecast, by country
- 8.4.6.1 Japan
- 8.4.6.1.1 Market size and forecast, by Application
- 8.4.6.1.2 Market size and forecast, by Target Area
- 8.4.6.1.3 Market size and forecast, by Disease Indication
- 8.4.6.1.4 Market size and forecast, by End User
- 8.4.6.2 China
- 8.4.6.2.1 Market size and forecast, by Application
- 8.4.6.2.2 Market size and forecast, by Target Area
- 8.4.6.2.3 Market size and forecast, by Disease Indication
- 8.4.6.2.4 Market size and forecast, by End User
- 8.4.6.3 Australia
- 8.4.6.3.1 Market size and forecast, by Application
- 8.4.6.3.2 Market size and forecast, by Target Area
- 8.4.6.3.3 Market size and forecast, by Disease Indication
- 8.4.6.3.4 Market size and forecast, by End User
- 8.4.6.4 India
- 8.4.6.4.1 Market size and forecast, by Application
- 8.4.6.4.2 Market size and forecast, by Target Area
- 8.4.6.4.3 Market size and forecast, by Disease Indication
- 8.4.6.4.4 Market size and forecast, by End User
- 8.4.6.5 South Korea
- 8.4.6.5.1 Market size and forecast, by Application
- 8.4.6.5.2 Market size and forecast, by Target Area
- 8.4.6.5.3 Market size and forecast, by Disease Indication
- 8.4.6.5.4 Market size and forecast, by End User
- 8.4.6.6 Rest Of Asia Pacific
- 8.4.6.6.1 Market size and forecast, by Application
- 8.4.6.6.2 Market size and forecast, by Target Area
- 8.4.6.6.3 Market size and forecast, by Disease Indication
- 8.4.6.6.4 Market size and forecast, by End User
- 8.5 LAMEA
- 8.5.1 Key trends and opportunities
- 8.5.2 LAMEA Market size and forecast, by Application
- 8.5.3 LAMEA Market size and forecast, by Target Area
- 8.5.4 LAMEA Market size and forecast, by Disease Indication
- 8.5.5 LAMEA Market size and forecast, by End User
- 8.5.6 LAMEA Market size and forecast, by country
- 8.5.6.1 Brazil
- 8.5.6.1.1 Market size and forecast, by Application
- 8.5.6.1.2 Market size and forecast, by Target Area
- 8.5.6.1.3 Market size and forecast, by Disease Indication
- 8.5.6.1.4 Market size and forecast, by End User
- 8.5.6.2 South Africa,
- 8.5.6.2.1 Market size and forecast, by Application
- 8.5.6.2.2 Market size and forecast, by Target Area
- 8.5.6.2.3 Market size and forecast, by Disease Indication
- 8.5.6.2.4 Market size and forecast, by End User
- 8.5.6.3 Saudi Arabia
- 8.5.6.3.1 Market size and forecast, by Application
- 8.5.6.3.2 Market size and forecast, by Target Area
- 8.5.6.3.3 Market size and forecast, by Disease Indication
- 8.5.6.3.4 Market size and forecast, by End User
- 8.5.6.4 Rest of LAMEA
- 8.5.6.4.1 Market size and forecast, by Application
- 8.5.6.4.2 Market size and forecast, by Target Area
- 8.5.6.4.3 Market size and forecast, by Disease Indication
- 8.5.6.4.4 Market size and forecast, by End User
- CHAPTER 9: COMPANY LANDSCAPE
- 9.1. Introduction
- 9.2. Top winning strategies
- 9.3. Product Mapping of Top 10 Player
- 9.4. Competitive Dashboard
- 9.5. Competitive Heatmap
- 9.6. Key developments
- CHAPTER 10: COMPANY PROFILES
- 10.1 RF Co., Ltd
- 10.1.1 Company overview
- 10.1.2 Company snapshot
- 10.1.3 Operating business segments
- 10.1.4 Product portfolio
- 10.1.5 Business performance
- 10.1.6 Key strategic moves and developments
- 10.2 JINSHAN Science and Technology
- 10.2.1 Company overview
- 10.2.2 Company snapshot
- 10.2.3 Operating business segments
- 10.2.4 Product portfolio
- 10.2.5 Business performance
- 10.2.6 Key strategic moves and developments
- 10.3 Proteus Digital Health
- 10.3.1 Company overview
- 10.3.2 Company snapshot
- 10.3.3 Operating business segments
- 10.3.4 Product portfolio
- 10.3.5 Business performance
- 10.3.6 Key strategic moves and developments
- 10.4 HQ, Inc.
- 10.4.1 Company overview
- 10.4.2 Company snapshot
- 10.4.3 Operating business segments
- 10.4.4 Product portfolio
- 10.4.5 Business performance
- 10.4.6 Key strategic moves and developments
- 10.5 CapsoVision, Inc.
- 10.5.1 Company overview
- 10.5.2 Company snapshot
- 10.5.3 Operating business segments
- 10.5.4 Product portfolio
- 10.5.5 Business performance
- 10.5.6 Key strategic moves and developments
- 10.6 Medtronic Plc.
- 10.6.1 Company overview
- 10.6.2 Company snapshot
- 10.6.3 Operating business segments
- 10.6.4 Product portfolio
- 10.6.5 Business performance
- 10.6.6 Key strategic moves and developments
- 10.7 Olympus Corporations
- 10.7.1 Company overview
- 10.7.2 Company snapshot
- 10.7.3 Operating business segments
- 10.7.4 Product portfolio
- 10.7.5 Business performance
- 10.7.6 Key strategic moves and developments
- 10.8 IntroMedic Co., Ltd
- 10.8.1 Company overview
- 10.8.2 Company snapshot
- 10.8.3 Operating business segments
- 10.8.4 Product portfolio
- 10.8.5 Business performance
- 10.8.6 Key strategic moves and developments
- 10.9 Check Cap
- 10.9.1 Company overview
- 10.9.2 Company snapshot
- 10.9.3 Operating business segments
- 10.9.4 Product portfolio
- 10.9.5 Business performance
- 10.9.6 Key strategic moves and developments
- 10.10 Koninklijke Philips N.V
- 10.10.1 Company overview
- 10.10.2 Company snapshot
- 10.10.3 Operating business segments
- 10.10.4 Product portfolio
- 10.10.5 Business performance
- 10.10.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL SMART PILLS TECHNOLOGY MARKET, BY APPLICATION, 2020-2030,($MILLION)
- TABLE 2. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR CAPSULE ENDOSCOPY, BY REGION , 2020-2030,($MILLION)
- TABLE 3. SMART PILLS TECHNOLOGY MARKET CAPSULE ENDOSCOPY BY COUNTRY, 2020-2030,($MILLION)
- TABLE 4. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR DRUG DELIVERY, BY REGION , 2020-2030,($MILLION)
- TABLE 5. SMART PILLS TECHNOLOGY MARKET DRUG DELIVERY BY COUNTRY, 2020-2030,($MILLION)
- TABLE 6. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR PATIENT MONITORING, BY REGION , 2020-2030,($MILLION)
- TABLE 7. SMART PILLS TECHNOLOGY MARKET PATIENT MONITORING BY COUNTRY, 2020-2030,($MILLION)
- TABLE 8. GLOBAL SMART PILLS TECHNOLOGY MARKET, BY TARGET AREA, 2020-2030,($MILLION)
- TABLE 9. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR ESOPHAGUS, BY REGION , 2020-2030,($MILLION)
- TABLE 10. SMART PILLS TECHNOLOGY MARKET ESOPHAGUS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 11. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR STOMACH, BY REGION , 2020-2030,($MILLION)
- TABLE 12. SMART PILLS TECHNOLOGY MARKET STOMACH BY COUNTRY, 2020-2030,($MILLION)
- TABLE 13. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR SMALL INTESTINE, BY REGION , 2020-2030,($MILLION)
- TABLE 14. SMART PILLS TECHNOLOGY MARKET SMALL INTESTINE BY COUNTRY, 2020-2030,($MILLION)
- TABLE 15. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR LARGE INTESTINE, BY REGION , 2020-2030,($MILLION)
- TABLE 16. SMART PILLS TECHNOLOGY MARKET LARGE INTESTINE BY COUNTRY, 2020-2030,($MILLION)
- TABLE 17. GLOBAL SMART PILLS TECHNOLOGY MARKET, BY DISEASE INDICATION, 2020-2030,($MILLION)
- TABLE 18. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR BARRETT'S ESOPHAGUS, BY REGION , 2020-2030,($MILLION)
- TABLE 19. SMART PILLS TECHNOLOGY MARKET BARRETT'S ESOPHAGUS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 20. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR SMALL BOWEL DISEASES, BY REGION , 2020-2030,($MILLION)
- TABLE 21. SMART PILLS TECHNOLOGY MARKET SMALL BOWEL DISEASES BY COUNTRY, 2020-2030,($MILLION)
- TABLE 22. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR COLON CANCER, BY REGION , 2020-2030,($MILLION)
- TABLE 23. SMART PILLS TECHNOLOGY MARKET COLON CANCER BY COUNTRY, 2020-2030,($MILLION)
- TABLE 24. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
- TABLE 25. SMART PILLS TECHNOLOGY MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 26. GLOBAL SMART PILLS TECHNOLOGY MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 27. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR HOSPITALS AND CLINICS, BY REGION , 2020-2030,($MILLION)
- TABLE 28. SMART PILLS TECHNOLOGY MARKET HOSPITALS AND CLINICS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 29. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR DIAGNOSTIC CENTRES, BY REGION , 2020-2030,($MILLION)
- TABLE 30. SMART PILLS TECHNOLOGY MARKET DIAGNOSTIC CENTRES BY COUNTRY, 2020-2030,($MILLION)
- TABLE 31. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR RESEARCH CENTRES, BY REGION , 2020-2030,($MILLION)
- TABLE 32. SMART PILLS TECHNOLOGY MARKET RESEARCH CENTRES BY COUNTRY, 2020-2030,($MILLION)
- TABLE 33. SMART PILLS TECHNOLOGY MARKET, BY REGION, 2020-2030,($MILLION)
- TABLE 34. NORTH AMERICA SMART PILLS TECHNOLOGY MARKET, BY APPLICATION, 2020-2030,($MILLION)
- TABLE 35. NORTH AMERICA SMART PILLS TECHNOLOGY MARKET, BY TARGET AREA, 2020-2030,($MILLION)
- TABLE 36. NORTH AMERICA SMART PILLS TECHNOLOGY MARKET, BY DISEASE INDICATION, 2020-2030,($MILLION)
- TABLE 37. NORTH AMERICA SMART PILLS TECHNOLOGY MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 38. NORTH AMERICA SMART PILLS TECHNOLOGY MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 39. U.S. SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 40. U.S. SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
- TABLE 41. U.S. SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
- TABLE 42. U.S. SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
- TABLE 43. CANADA SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 44. CANADA SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
- TABLE 45. CANADA SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
- TABLE 46. CANADA SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
- TABLE 47. MEXICO SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 48. MEXICO SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
- TABLE 49. MEXICO SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
- TABLE 50. MEXICO SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
- TABLE 51. EUROPE SMART PILLS TECHNOLOGY MARKET, BY APPLICATION, 2020-2030,($MILLION)
- TABLE 52. EUROPE SMART PILLS TECHNOLOGY MARKET, BY TARGET AREA, 2020-2030,($MILLION)
- TABLE 53. EUROPE SMART PILLS TECHNOLOGY MARKET, BY DISEASE INDICATION, 2020-2030,($MILLION)
- TABLE 54. EUROPE SMART PILLS TECHNOLOGY MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 55. EUROPE SMART PILLS TECHNOLOGY MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 56. GERMANY SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 57. GERMANY SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
- TABLE 58. GERMANY SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
- TABLE 59. GERMANY SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
- TABLE 60. FRANCE SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 61. FRANCE SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
- TABLE 62. FRANCE SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
- TABLE 63. FRANCE SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
- TABLE 64. U.K. SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 65. U.K. SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
- TABLE 66. U.K. SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
- TABLE 67. U.K. SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
- TABLE 68. ITALY SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 69. ITALY SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
- TABLE 70. ITALY SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
- TABLE 71. ITALY SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
- TABLE 72. SPAIN SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 73. SPAIN SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
- TABLE 74. SPAIN SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
- TABLE 75. SPAIN SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
- TABLE 76. REST OF EUROPE SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 77. REST OF EUROPE SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
- TABLE 78. REST OF EUROPE SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
- TABLE 79. REST OF EUROPE SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
- TABLE 80. ASIA-PACIFIC SMART PILLS TECHNOLOGY MARKET, BY APPLICATION, 2020-2030,($MILLION)
- TABLE 81. ASIA-PACIFIC SMART PILLS TECHNOLOGY MARKET, BY TARGET AREA, 2020-2030,($MILLION)
- TABLE 82. ASIA-PACIFIC SMART PILLS TECHNOLOGY MARKET, BY DISEASE INDICATION, 2020-2030,($MILLION)
- TABLE 83. ASIA-PACIFIC SMART PILLS TECHNOLOGY MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 84. ASIA-PACIFIC SMART PILLS TECHNOLOGY MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 85. JAPAN SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 86. JAPAN SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
- TABLE 87. JAPAN SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
- TABLE 88. JAPAN SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
- TABLE 89. CHINA SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 90. CHINA SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
- TABLE 91. CHINA SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
- TABLE 92. CHINA SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
- TABLE 93. AUSTRALIA SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 94. AUSTRALIA SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
- TABLE 95. AUSTRALIA SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
- TABLE 96. AUSTRALIA SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
- TABLE 97. INDIA SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 98. INDIA SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
- TABLE 99. INDIA SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
- TABLE 100. INDIA SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
- TABLE 101. SOUTH KOREA SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 102. SOUTH KOREA SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
- TABLE 103. SOUTH KOREA SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
- TABLE 104. SOUTH KOREA SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
- TABLE 105. REST OF ASIA PACIFIC SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 106. REST OF ASIA PACIFIC SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
- TABLE 107. REST OF ASIA PACIFIC SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
- TABLE 108. REST OF ASIA PACIFIC SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
- TABLE 109. LAMEA SMART PILLS TECHNOLOGY MARKET, BY APPLICATION, 2020-2030,($MILLION)
- TABLE 110. LAMEA SMART PILLS TECHNOLOGY MARKET, BY TARGET AREA, 2020-2030,($MILLION)
- TABLE 111. LAMEA SMART PILLS TECHNOLOGY MARKET, BY DISEASE INDICATION, 2020-2030,($MILLION)
- TABLE 112. LAMEA SMART PILLS TECHNOLOGY MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 113. LAMEA SMART PILLS TECHNOLOGY MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 114. BRAZIL SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 115. BRAZIL SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
- TABLE 116. BRAZIL SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
- TABLE 117. BRAZIL SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
- TABLE 118. SOUTH AFRICA, SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 119. SOUTH AFRICA, SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
- TABLE 120. SOUTH AFRICA, SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
- TABLE 121. SOUTH AFRICA, SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
- TABLE 122. SAUDI ARABIA SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 123. SAUDI ARABIA SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
- TABLE 124. SAUDI ARABIA SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
- TABLE 125. SAUDI ARABIA SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
- TABLE 126. REST OF LAMEA SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
- TABLE 127. REST OF LAMEA SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
- TABLE 128. REST OF LAMEA SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
- TABLE 129. REST OF LAMEA SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
- TABLE 130.RF CO., LTD: COMPANY SNAPSHOT
- TABLE 131.RF CO., LTD: OPERATING SEGMENTS
- TABLE 132.RF CO., LTD: PRODUCT PORTFOLIO
- TABLE 133.RF CO., LTD: NET SALES,
- TABLE 134.RF CO., LTD: KEY STRATERGIES
- TABLE 135.JINSHAN SCIENCE AND TECHNOLOGY: COMPANY SNAPSHOT
- TABLE 136.JINSHAN SCIENCE AND TECHNOLOGY: OPERATING SEGMENTS
- TABLE 137.JINSHAN SCIENCE AND TECHNOLOGY: PRODUCT PORTFOLIO
- TABLE 138.JINSHAN SCIENCE AND TECHNOLOGY: NET SALES,
- TABLE 139.JINSHAN SCIENCE AND TECHNOLOGY: KEY STRATERGIES
- TABLE 140.PROTEUS DIGITAL HEALTH: COMPANY SNAPSHOT
- TABLE 141.PROTEUS DIGITAL HEALTH: OPERATING SEGMENTS
- TABLE 142.PROTEUS DIGITAL HEALTH: PRODUCT PORTFOLIO
- TABLE 143.PROTEUS DIGITAL HEALTH: NET SALES,
- TABLE 144.PROTEUS DIGITAL HEALTH: KEY STRATERGIES
- TABLE 145.HQ, INC.: COMPANY SNAPSHOT
- TABLE 146.HQ, INC.: OPERATING SEGMENTS
- TABLE 147.HQ, INC.: PRODUCT PORTFOLIO
- TABLE 148.HQ, INC.: NET SALES,
- TABLE 149.HQ, INC.: KEY STRATERGIES
- TABLE 150.CAPSOVISION, INC.: COMPANY SNAPSHOT
- TABLE 151.CAPSOVISION, INC.: OPERATING SEGMENTS
- TABLE 152.CAPSOVISION, INC.: PRODUCT PORTFOLIO
- TABLE 153.CAPSOVISION, INC.: NET SALES,
- TABLE 154.CAPSOVISION, INC.: KEY STRATERGIES
- TABLE 155.MEDTRONIC PLC.: COMPANY SNAPSHOT
- TABLE 156.MEDTRONIC PLC.: OPERATING SEGMENTS
- TABLE 157.MEDTRONIC PLC.: PRODUCT PORTFOLIO
- TABLE 158.MEDTRONIC PLC.: NET SALES,
- TABLE 159.MEDTRONIC PLC.: KEY STRATERGIES
- TABLE 160.OLYMPUS CORPORATIONS: COMPANY SNAPSHOT
- TABLE 161.OLYMPUS CORPORATIONS: OPERATING SEGMENTS
- TABLE 162.OLYMPUS CORPORATIONS: PRODUCT PORTFOLIO
- TABLE 163.OLYMPUS CORPORATIONS: NET SALES,
- TABLE 164.OLYMPUS CORPORATIONS: KEY STRATERGIES
- TABLE 165.INTROMEDIC CO., LTD: COMPANY SNAPSHOT
- TABLE 166.INTROMEDIC CO., LTD: OPERATING SEGMENTS
- TABLE 167.INTROMEDIC CO., LTD: PRODUCT PORTFOLIO
- TABLE 168.INTROMEDIC CO., LTD: NET SALES,
- TABLE 169.INTROMEDIC CO., LTD: KEY STRATERGIES
- TABLE 170.CHECK CAP: COMPANY SNAPSHOT
- TABLE 171.CHECK CAP: OPERATING SEGMENTS
- TABLE 172.CHECK CAP: PRODUCT PORTFOLIO
- TABLE 173.CHECK CAP: NET SALES,
- TABLE 174.CHECK CAP: KEY STRATERGIES
- TABLE 175.KONINKLIJKE PHILIPS N.V: COMPANY SNAPSHOT
- TABLE 176.KONINKLIJKE PHILIPS N.V: OPERATING SEGMENTS
- TABLE 177.KONINKLIJKE PHILIPS N.V: PRODUCT PORTFOLIO
- TABLE 178.KONINKLIJKE PHILIPS N.V: NET SALES,
- TABLE 179.KONINKLIJKE PHILIPS N.V: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.SMART PILLS TECHNOLOGY MARKET SEGMENTATION
- FIGURE 2.SMART PILLS TECHNOLOGY MARKET,2020-2030
- FIGURE 3.SMART PILLS TECHNOLOGY MARKET,2020-2030
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.SMART PILLS TECHNOLOGY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 11.SMART PILLS TECHNOLOGY MARKET,BY APPLICATION,2020(%)
- FIGURE 12.COMPARATIVE SHARE ANALYSIS OF CAPSULE ENDOSCOPY SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DRUG DELIVERY SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF PATIENT MONITORING SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
- FIGURE 15.SMART PILLS TECHNOLOGY MARKET,BY TARGET AREA,2020(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF ESOPHAGUS SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF STOMACH SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF SMALL INTESTINE SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF LARGE INTESTINE SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
- FIGURE 20.SMART PILLS TECHNOLOGY MARKET,BY DISEASE INDICATION,2020(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF BARRETT'S ESOPHAGUS SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF SMALL BOWEL DISEASES SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF COLON CANCER SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
- FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
- FIGURE 25.SMART PILLS TECHNOLOGY MARKET,BY END USER,2020(%)
- FIGURE 26.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
- FIGURE 27.COMPARATIVE SHARE ANALYSIS OF DIAGNOSTIC CENTRES SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
- FIGURE 28.COMPARATIVE SHARE ANALYSIS OF RESEARCH CENTRES SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
- FIGURE 29.SMART PILLS TECHNOLOGY MARKET BY REGION,2020
- FIGURE 30.U.S. SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
- FIGURE 31.CANADA SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
- FIGURE 32.MEXICO SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
- FIGURE 33.GERMANY SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
- FIGURE 34.FRANCE SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
- FIGURE 35.U.K. SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
- FIGURE 36.ITALY SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
- FIGURE 37.SPAIN SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
- FIGURE 38.REST OF EUROPE SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
- FIGURE 39.JAPAN SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
- FIGURE 40.CHINA SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
- FIGURE 41.AUSTRALIA SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
- FIGURE 42.INDIA SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
- FIGURE 43.SOUTH KOREA SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
- FIGURE 44.REST OF ASIA PACIFIC SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
- FIGURE 45.BRAZIL SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
- FIGURE 46.SOUTH AFRICA, SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
- FIGURE 47.SAUDI ARABIA SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
- FIGURE 48.REST OF LAMEA SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
- FIGURE 49. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 50. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 51. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 52.PRODUCT MAPPING OF TOP 10 PLAYERS
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook